In particular, IFNγ, leptin, TGFβ1, TIMP1, TIMP2, thrombopoietin and VEGF levels were significantly inhibited by anandamide in the conditioned medium of MDA-MB-231 breast cancer cells. This evidence concerns the gene TGFB1 and breast carcinoma.